Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • HIV Infection
  • Human Immunodeficiency Virus 1 Positive
  • Malignant Neoplasm
  • Recurrent Malignant Neoplasm
Type
Observational
Design
Observational Model: Case-OnlyTime Perspective: Prospective

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

PRIMARY OBJECTIVES: I. To determine the number of diagnosed cancers in people living with HIV/AIDS (PLWHA) presenting to participating clinical sites in Latin America, and estimate site-specific prevalence based on all presenting cancers (new diagnosis, recurrence, and surveillance cases) and site-s...

PRIMARY OBJECTIVES: I. To determine the number of diagnosed cancers in people living with HIV/AIDS (PLWHA) presenting to participating clinical sites in Latin America, and estimate site-specific prevalence based on all presenting cancers (new diagnosis, recurrence, and surveillance cases) and site-specific incidence based on newly diagnosed cancers. SECONDARY OBJECTIVES: I. Obtain information on the use of diagnostic testing and treatment for the cohort of diagnosed HIV-associated cancer participants. II. To collect information on participant characteristics for diagnosed HIV-associated cancers (e.g., antiretroviral therapy [ART] regimen, current CD4 count, current viral load, etc.). EXPLORATORY OBJECTIVES: I. To determine the timelines and requirements for protocol review and approval at the local, regional, and national level. II. To familiarize local sites with the online data entry systems utilized by the AIDS Malignancy Consortium (AMC). OUTLINE: Patients respond to surveys and/or undergo medical record review at baseline and at 4 weeks.

Tracking Information

NCT #
NCT04089488
Collaborators
  • National Cancer Institute (NCI)
  • The Emmes Company, LLC
  • University of Arkansas
Investigators
Principal Investigator: Robert M Strother AIDS Malignancy Consortium